NASDAQ:ESTA

Establishment Labs Holdings Stock News

etoro logo Buy ESTA
*Your capital is at risk
$92.54
-0.94 (-1.01%)
At Close: Jul 31, 2026
Establishment Labs (NASDAQ:ESTA) was downgraded by stock analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Tuesday, BidAskClub reports. A n
Wall Street brokerages expect Establishment Labs Holdings Inc (NASDAQ:ESTA) to post earnings of ($0.56) per share for the current quarter, Zacks reports. Zero analysts have issued estimates for Establ
In a report released yesterday, Marie Thibault from BTIG initiated coverage with a Buy rating on Establishment Labs Holdings (ESTA) and a price target of
In a report released yesterday, Marie Thibault from BTIG initiated coverage with a Buy rating on Establishment Labs Holdings (ESTA
Establishment Labs (NASDAQ:ESTA) and Ocugen (NASDAQ:OCGN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their divid
Establishment Labs (NASDAQ:ESTA) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a report released on Tuesday, ValuEngine reports. Separately, Zacks Investme
Avanos Medical (NYSE:AVNS) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of thei
Establishment Labs Holdings Inc. (ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announc
BigSur Wealth Management LLC purchased a new stake in Establishment Labs Holdings Inc (NASDAQ:ESTA) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm
Establishment Labs Holdings Inc. (ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announc
NEW YORK, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on...
Establishment Labs Holdings (NASDAQ:ESTA) is down 3.5% after announcing preliminary Q4 results and filing to offer $55M in common shares. Preliminary revenue for Q4 is expected at $23.5M-$24.5M (abov
Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced preliminary finan
NEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health –...
Establishment Labs Holdings Inc. (ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announc
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE